Institute of Endocrinology, Lithuanian University of Health Sciences, Eiveniu str. 2, LT-50161, Kaunas, Lithuania.
Psychiatry Clinic, Lithuanian University of Health Sciences, Kaunas, Lithuania.
BMC Psychiatry. 2018 Jan 8;18(1):5. doi: 10.1186/s12888-017-1576-8.
Depressive and anxiety disorders are common in primary care setting but often remain undiagnosed. Metabolic syndrome (MetS) is also prevalent in the general population and can impair recognition of common mental disorders due to significant co-morbidity and overlap with psychiatric symptoms included in self-reported depression/anxiety screening tools. We investigated if MetS has an impact on the accuracy of current major depressive disorder (MDD) and generalized anxiety disorder (GAD) screening results using the Hospital Anxiety and Depression scale (HADS).
A total of 1115 (562 men; mean age 62.0 ± 9.6 years) individuals of 45+ years of age were randomly selected from the general population and evaluated for current MetS; depressive and anxiety symptoms (HADS); and current MDD and GAD (Mini International Neuropsychiatric Interview [MINI]).
The MetS was diagnosed in 34.4% of the study participants. Current MDD and GAD were more common in individuals with MetS relative to individuals without MetS (25.3% vs 14.2%, respectively, p < 0.001; and 30.2% vs 20.9%, respectively, p < 0.001). The ROC analyses demonstrated that optimal thresholds of the HADS-Depression subscale for current MDE were ≥9 in individuals with MetS (sensitivity = 87%, specificity = 73% and PPV = 52%) and ≥8 in individuals without MetS (sensitivity = 81%, specificity = 78% and PPV = 38%). At threshold of ≥9 the HADS-Anxiety subscale demonstrated optimal psychometric properties for current GAD screening in individuals with MetS (sensitivity = 91%, specificity = 85% and PPV = 72%) and without MetS (sensitivity = 84%, specificity = 83% and PPV = 56%).
The HADS is a reliable screening tool for current MDE and GAD in middle aged and elderly population with and without MetS. Optimal thresholds of the HADS-Depression subscale for current MDD is ≥9 for individuals with MetS and ≥8 - without MetS. Optimal threshold of the HADS-Anxiety subscale is ≥9 for current GAD in individuals with and without MetS. The presence of MetS should be considered when interpreting depression screening results.
抑郁和焦虑障碍在初级保健环境中很常见,但往往未被诊断出来。代谢综合征(MetS)在普通人群中也很普遍,由于与自我报告的抑郁/焦虑筛查工具中包含的精神症状有显著的共病和重叠,它可能会影响常见精神障碍的识别。我们使用医院焦虑和抑郁量表(HADS)研究了代谢综合征是否会影响当前重度抑郁症(MDD)和广泛性焦虑症(GAD)筛查结果的准确性。
共随机选择了 1115 名(562 名男性;平均年龄 62.0±9.6 岁)45 岁以上的普通人群个体,评估其当前的代谢综合征;抑郁和焦虑症状(HADS);以及当前的 MDD 和 GAD(迷你国际神经精神病访谈 [MINI])。
研究参与者中有 34.4%被诊断为代谢综合征。与无代谢综合征的个体相比,患有代谢综合征的个体更常见当前 MDD 和 GAD(分别为 25.3%和 30.2%,均 p<0.001;分别为 14.2%和 20.9%,均 p<0.001)。ROC 分析表明,对于患有代谢综合征的个体,HADS 抑郁分量表的当前 MDE 最佳截断值为≥9(敏感性=87%,特异性=73%和 PPV=52%)和无代谢综合征的个体(敏感性=81%,特异性=78%和 PPV=38%)。在阈值≥9时,HADS 焦虑分量表在患有代谢综合征的个体中表现出当前 GAD 筛查的最佳心理测量特性(敏感性=91%,特异性=85%和 PPV=72%)和无代谢综合征(敏感性=84%,特异性=83%和 PPV=56%)。
HADS 是一种可靠的筛查工具,用于筛查患有和不患有代谢综合征的中年和老年人群的当前 MDE 和 GAD。对于患有代谢综合征的个体,当前 MDD 的 HADS 抑郁分量表的最佳截断值为≥9,对于无代谢综合征的个体为≥8。对于患有和不患有代谢综合征的个体,HADS 焦虑分量表的最佳截断值为≥9 用于当前 GAD。在解释抑郁筛查结果时,应考虑代谢综合征的存在。